I’ve tried everything,” Dr. Nathaniel Chin, an associate professor at the University of Wisconsin Department of Medicine, told The Post.

Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart health, reduce infections, lower substance abuse risks, and even decrease the chance of dementia.

Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes ... your risk of developing a host of different health issues, including dementia. Of course, it isn't all positive. The scientists also found that these ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease and psychotic disorders.

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia,

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal Alzheimer's and Dementia: Translational Research & Clinical Interventions .

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes,

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.

It is the memory-robbing disease that people fear the most as they age - and it is even more tragic when it strikes early. One of those affected is actress Pauline Quirke.

A recent study from Karolinska Institutet suggests that a type of diabetes medication called GLP-1 agonists could reduce the risk of dementia in people with type 2 diabetes. The study, published in eClinicalMedicine,